Page 3 - Cbvs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cbvs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cbvs Today - Breaking & Trending Today
Bioventus Inc. (NYSE:BVS – Get Free Report) major shareholder Juniper Investment Company, Ll bought 14,985 shares of the stock in a transaction dated Monday, August 14th. The shares were acquired at an average price of $4.79 per share, for a total transaction of $71,778.15. Following the completion of the transaction, the insider now owns 6,833,857 […] ....
Bioventus (NYSE:BVS – Get Free Report) updated its FY 2023 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of -$0.24–$0.20 for the period, compared to the consensus estimate of -$0.22. The company issued revenue guidance of $490.00 million-$505.00 million, compared to the consensus revenue estimate of $493.14 million. Bioventus Price Performance […] ....
Bioventus (NYSE:BVS – Free Report) and Revolutions Medical (OTCMKTS:RMCP – Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings. Earnings and Valuation This table compares Bioventus and Revolutions Medical’s gross […] ....
Bravura Solutions Limited (ASX:BVS – Get Rating) insider Matthew Quinn acquired 350,000 shares of the stock in a transaction that occurred on Thursday, June 1st. The stock was purchased at an average price of A$0.48 ($0.32) per share, for a total transaction of A$166,600.00 ($110,331.13). Bravura Solutions Price Performance The company has a quick ratio […] ....
Bioventus Inc. (NYSE:BVS – Get Rating) Director John A. Bartholdson bought 178,998 shares of the stock in a transaction on Monday, May 22nd. The shares were acquired at an average cost of $2.08 per share, with a total value of $372,315.84. Following the purchase, the director now owns 5,909,136 shares of the company’s stock, valued […] ....